London, UK (PRWEB) May 1, 2008
In its continued drive to provide a full range of services to pharmaceutical companies, Kinapse has launched 'Commercial Excellence', a suite of business consulting and information processing services for pharmaceutical marketing and sales organisations.
The business consulting services focus on the key areas of portfolio, product and operating strategy. Portfolio and product strategy include portfolio and product evaluation, development of therapeutic/disease area strategy, market opportunity assessment, product launch strategy and planning, competitor analysis, strategy for marketed brands and divestment strategy. Operating strategy includes organisational and process design, resource management and performance management.
Information processing services features offerings in commercial data analytics and scientific communications. Commercial data analytics includes performance tracking and reporting, planning and forecasting, scenario modelling and resource effectiveness and optimisation. Scientific communications includes strategic publications planning, development of promotional materials and congress / symposium support. These are in addition to Kinapse's existing Medical Writing and Medical Information services.
All services are enabled by Kinapse's proven onshore-offshore delivery model.
In addition, to enhance these services and to further strengthen its senior delivery team, Kinapse is pleased to announce the induction of Chris Thomas and Sally Church as Kinapse Consulting Partners.
Chris Thomas, based in the UK, has over 35 years of experience in the pharmaceutical industry, including over 25 years in marketing and sales at major pharmaceutical companies, including Bayer and Astra. Chris is currently Marketing Partner at Oxford PharmaGenesis, part of Kinapse's strong and expanding service partnership network.
Dr Sally Church, based in New York, USA, has over 20 years of life sciences sector experience. Her career at Novartis spanned the UK and US in senior roles in strategic planning, business development, sales and marketing. Sally now runs Icarus Consultants, a management consulting firm specialising in new product development and launches.
Andy Black, the CEO of Kinapse, commented: "The launch of 'Commercial Excellence' is an important milestone in the continued growth of Kinapse. We fully expect to bring the same quality of delivery and client value to these services as we have attained through our many successful client relationships to date".
Shalabh Kumar, Kinapse COO, said "We are delighted to launch our 'Commercial Excellence' services. They are a key step towards our primary aim of creating value for clients in life sciences organisations in all aspects of their business. I am also delighted to welcome Sally and Chris to our Consulting Partner network, and look forward to leveraging their deep experience for the benefit of our clients".
'Collaborating with our clients to innovate for exceptional results'
Kinapse provides business consulting and information processing services to life sciences organisations. Its clients include many of the world's leading pharmaceutical companies, leading biotechnology, specialty pharmaceutical and medical devices companies, government organisations and industry service providers.
Headquartered in the UK, Kinapse has offices in London, Philadelphia and Delhi with partners based in the Americas, Europe and Asia Pacific. Kinapse blends expertise from its multiple locations to deliver services for clients at highest quality and differentiated value. The novel features of its operating model include:
- focus on life sciences;
- blended onshore-offshore teams, tailored to client requirements;
- industry-veteran Consulting Partners who bring deep experience and expertise in specific functional areas;
- exclusive Service Partners with distinctive, complementary services.
Chief Operating Officer
P: +44 20 8946 7600
Web site: http://www.kinapse.com
General enquiries: info @ kinapse.com
# # #